3. IMMUNOTHERAPEUTICS :-
IT IS ALSO SOMETIMES CALLED BIOLOGIC THERAPY OR BIOTHERAPY.
IT IS A TREATMENT THAT USES CERTAIN PARTS OF THE IMMUNE SYSTEM TO FIGHT DISEASE
SUCH AS CANCER.
IMMUNOTHERAPY IS THE TREATMENT OF DISEASE BY ACTIVATING OR SUPPRESSING THE
IMMUNE SYSTEM.
IT AIMS TO ACTIVATE THE BODY’S OWN DEFENCE MECHANISMS BY TRIGGERING OR MIMICKING
IMMUNE RESPONSES.
Immunotherapy can treat many different types of cancer.
4. How It Works ?
Immunotherapy includes a wide variety of treatments that work in different ways.
By boosting the body's immune system in a very general way.
Helps to train the immune system to attack cancer cells specifically.
Giving immune system components, such as man-made immune system proteins.
5. TYPES OF IMMUNOTHERAPY :-
The main types of immunotherapy now being used to treat cancer are:-
Monoclonal Antibodies.
Cancer Vaccines.
Non-Specific Immunotherapies.
Engineered Antibodies
6. MONOCLONAL ANTIBODIES :-
Monoclonal antibodies are man-made proteins that act like human antibodies.
These Antibodies can be useful in fighting diseases because they can designed specifically to only target a
certain antigen, such as one that is found on cancer cells.
Many copies of a specific Antibody can be made in the lab. These are known as Monoclonal Antibodies.
7. Cancer vaccines :-
Cancer vaccines are made up from -
Dead cancer cells
Proteins from cancer cells
Immune system cells
These use your immune system to prevent cancer and or treat cancer.
8. Non-specific immunotherapies :-
Most non-specific immunotherapies also help the immune system destroy cancer cells and given after or
at the same time as other cancer treatments.
Two common non-specific immunotherapies are Interferon and Interleukins.
interferon help the immune system fight cancer and may slow the growth of cancer cells.
interleukin help the immune system produce cells that destr0y cancer.
interleukin made in the laboratory is called Interleuukin-2 or aldesleukin.
9. HUMANIZATION ANTIBODY THERAPY:-
Humanization is now a well-established technique for reducing the immunogenicity of monoclonal
antibody from xenogeneic sources and for their activation of the human immune system.
Humanized antibodies are antibodies from non-human species whose protein sequences have been
modified to increase their similarity to antibody variants produced naturally in humans.
The process of humanization is usually applied to monoclonal antibodies developed for administration to
humans e.g. Antibodies developed as anti- cancer drugs.